Latham SL

ORCID: 0000-0003-1128-5315 · 1 paper in corpus · active 2022
2022
Non-kinase targeting of oncogenic c-Jun N-terminal kinase (JNK) signaling: the future of clinically viable cancer treatments.
Biochemical Society transactions ·doi:10.1042/bst20220808

c-Jun N-terminal Kinases (JNKs) have been identified as key disease drivers in a number of pathophysiological settings and central oncogenic signaling nodes in various cancers. Their roles in driving primary tumor growth, positively regulat…